| Date Filed | Type | Description |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Lynch Karen S (President and CEO) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 93,677 shares
@ $74.31, valued at
$7M
Granted 244,952 options to buy
@ $74.31, valued at
$18.2M
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Lynch Karen S (President and CEO) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 116,940 shares
@ $101.09, valued at
$11.8M
Granted 171,517 options
@ $101.09, valued at
$17.3M
|
|
| 02/23/2022 |
4
| Lynch Karen S (President and CEO) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 257,916 shares
@ $0 |
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| Lynch Karen S (President and CEO) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 14,121 shares
@ $91.52, valued at
$1.3M
|
|
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 33 options to buy
@ $45.59, valued at
$1.5k
|
|
| 12/04/2020 |
4
| Lynch Karen S (EVP and President, Aetna) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 12,779 shares
@ $69.63, valued at
$889.8k
|
|
| 04/27/2020 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 2,098 options to buy
@ $33.37, valued at
$70k
Granted 3,196 restricted stock units
@ $33.37, valued at
$106.7k
|
|
| 04/07/2020 |
4/A
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 211,196 options
@ $0 |
|
| 04/03/2020 |
4
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 211,196 options
@ $58.61, valued at
$12.4M
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 12,778 shares
@ $75.55, valued at
$965.4k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2019 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 1,123 options to buy
@ $51.21, valued at
$57.5k
Granted 3,124 restricted stock units
@ $51.21, valued at
$160k
|
|
| 04/03/2019 |
4
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 242,408 options
@ $54.19, valued at
$13.1M
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2018 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 132 options to buy
@ $45.65, valued at
$6k
|
|
| 12/06/2018 |
4
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Paid exercise price by delivering 13,060 shares
@ $79.52, valued at
$1M
|
|
| 11/30/2018 |
4
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 4 on CVS HEALTH Corp|
Txns:
| Granted 62,747 shares
@ $0
Granted 201,215 shares
@ $0
Granted 31,144 shares
@ $80.27, valued at
$2.5M
Granted 192,741 rights
@ $45.91, valued at
$8.8M
Granted 93,989 rights
@ $37.91, valued at
$3.6M
|
|
| 11/30/2018 |
3
| Lynch Karen S (EVP & Pres, Aetna Bus Unit) has filed a Form 3 on CVS HEALTH Corp |
| 11/28/2018 |
4
| Lynch Karen S (President) has filed a Form 4 on AETNA INC /PA/|
Txns:
| Disposed/sold 74,896 shares
@ $0
Disposed/sold 110,209 rights
@ $100.5, valued at
$11.1M
Disposed/sold 103,323 rights
@ $103.45, valued at
$10.7M
Disposed/sold 105,941 rights
@ $125.27, valued at
$13.3M
Disposed/sold 29,580 rights
@ $0
Disposed/sold 13,172 rights
@ $0
Disposed/sold 30,981 restricted stock units
@ $0 |
|
| 04/23/2018 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 2,959 restricted stock units
@ $50.7, valued at
$150k
Granted 2,012 options to buy
@ $50.7, valued at
$102k
|
|
| 03/06/2018 |
4
| Lynch Karen S (President) has filed a Form 4 on AETNA INC /PA/|
Txns:
| Paid exercise price by delivering 7,277 shares
@ $177.53, valued at
$1.3M
Exercised 14,926 rights
@ $0
Granted 30,981 restricted stock units
@ $0 |
|
| 01/29/2018 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 561 options to buy
@ $57.98, valued at
$32.5k
|
|
| 01/22/2018 |
4
| Lynch Karen S (Director) has filed a Form 4 on US BANCORP \DE\|
Txns:
| Granted 890 restricted stock units
@ $56.15, valued at
$50k
|
|
| 12/21/2017 |
4
| Lynch Karen S (President) has filed a Form 4 on AETNA INC /PA/|
Txns:
| Granted 14,926 rights
@ $0 |
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|